A document made public recently by the Senate's Special Committee on Aging provides an outline of the many steps Forest Laboratories used to make the antidepressant drug Lexapro a success. And one of the principal means by which Forest hoped to persuade psychiatrists, primary care doctors, and other medical specialists to prescribe Lexapro was by finding many ways to put money into doctors pockets, according to the New York Times.